论文部分内容阅读
癌症进展程度的正确记载与分类,对于制定治疗计划、显示预后、评价疗效、交流信息及人类癌症研究等都具有重要意义。自1979年1月开始使用肺癌TNM分类法以来,曾对其不完善之处进行了修改,并于1987年又公布了修改后新的TNM分类法。现结合作者对肺癌治疗的效果对其加以介绍。TNM分类法分为两类:手术前从临床检查中所获资料,对肺癌病变的估计为临床TNM分类(c-TNM);以手术切除的病理标本为基础,结合术中所见与临床资料对肺癌病变的分类为病理学TNM分类(p-TNM)。以T表示原发肿瘤、N表示淋巴结,M指转移情况。按不同情况组成各病期,见表1。
The correct recording and classification of the degree of cancer progression is of great significance for the formulation of treatment plans, the display of prognosis, the evaluation of efficacy, the exchange of information, and human cancer research. Since the introduction of the TNM classification of lung cancer in January 1979, the imperfections have been modified, and in 1987 the revised TNM classification was published. This is combined with the author’s presentation on the effectiveness of lung cancer treatment. TNM classification is divided into two categories: preoperative data obtained from clinical examinations, lung cancer lesions estimated as clinical TNM classification (c-TNM); based on surgical resection of pathological specimens, combined with intraoperative findings and clinical data Classification of lung cancer lesions is pathological TNM classification (p-TNM). The primary tumor is represented by T, the lymph node by N, and the metastatic condition. According to different conditions to form the disease period, see Table 1.